Physician profile
Collie B Shaw
NPI 1598763641
$1,043.25
in general payments reported to CMS, 2019-2025
18 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $218 · 2020: $170 · 2021: $173 · 2022: $229 · 2023: $58.54 · 2024: $73.27 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $253.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $237.21 | 2019-2020 | |
| Stryker Corporation | $210.21 | 2019-2024 | Audion Et Dilation System |
| Glaxosmithkline, LLC. | $164.56 | 2021-2025 | Nucala |
| Aerin Medical INC. | $64.66 | 2021-2023 | |
| Regeneron Healthcare Solutions, INC. | $54.62 | 2021-2022 | |
| Harmony Biosciences LLC | $46.04 | 2021-2022 | |
| Optinose US, INC. | $37.13 | 2021-2022 | |
| Hikma Pharmaceuticals USA | $37.11 | 2023-2024 | Ryaltris |
| Greer Laboratories, INC. | $32.05 | 2022 | |
| Jazz Pharmaceuticals INC. | $24.27 | 2021 | |
| Smith+Nephew, INC. | $22.27 | 2025 | Grafix Pl, Stravix |
| Merck Sharp & Dohme LLC | $19.66 | 2021 | |
| Abbvie INC. | $18.66 | 2025 | |
| Genentech USA, INC. | $17.02 | 2023 | Ocrevus |
| Madrigal Pharmaceuticals | $15.78 | 2025 | Rezdiffra |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $15.35 | 2022 | |
| Acclarent, INC | $14.97 | 2019 | |
| Alk-Abello, INC | $11.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Collie Shaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.